Back to search
FDAFDA · Food and drugs·Recall number D-0759-2022

quinapril HCl/hydrochlorothiazide tablets, 20 mg/12.5 mg*, 90 Tablets bottles, Rx Only, Distributed by: Greenstone, LLC, Peapack, NJ, 07977, Made in Germany, NDC 59762-0220-1

Published April 13, 2022 · Recall initiated: March 21, 2022

Summary

FDA records drug Class II recall D-0759-2022, published April 13, 2022 and initiated March 21, 2022. Recalling firm: Pfizer Inc.; Status: Terminated; Reported quantity: 21108 bottles; Lot: Lots DN6931, ED3904 & ED3905; Exp. 03/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Pfizer Inc.
Distributor
Nationwide
Lot
Lots DN6931, ED3904 & ED3905; Exp. 03/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was quinapril HCl/hydrochlorothiazide tablets, 20 mg/12.5 mg*, 90 Tablets bottles, Rx Only, Distributed by: Greenstone, LLC, Peapack, NJ, 07977, Made in Germany, NDC 59762-0220-1 recalled?

Yes. FDA published recall D-0759-2022 on April 13, 2022. Reported hazard: CGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release